The newly launched biotech is equipped with rights to a trio of weight loss medicines licensed from China-based Sciwind ...

The series A fundraising is the biggest ever for a European biotech firm, according to the data provider PitchBook.

Newly launched company, Verdiva Bio, is aiming to advance oral and injectable drugs for obesity, with it backed by an ...

Financing was co-led by Forbion and General Atlantic, with participants such as RA Capital Management, OrbiMed, and Lilly ...

Verdiva Bio Limited ("Verdiva" or "the Company") today announced its launch as a clinical ... Previously, Dr. Eid held senior clinical, medical, and regulatory roles at Novo Nordisk. Dr. Eid notes, ...

We recently compiled a list of the 10 Best Stocks to Invest in According to Billionaire Cliff Asness. In this article, we are ...

We recently compiled a list of the 9 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where Eli ...

Eventually, Musk reached a deal to acquire the company ... and Novo Nordisk. On 14 November, Eli Lilly became a part of this group, after an account using its name and logo sent out a Tweet, ...

The Company is advancing a portfolio of next-generation oral ... Previously, Dr. Eid held senior clinical, medical, and regulatory roles at Novo Nordisk. Dr. Eid notes, “We are excited by the ...

UBS analyst Jo Walton maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target of DKK750.00. The company’s ...

In a report released today, James Quigley from Goldman Sachs maintained a Buy rating on Novo Nordisk (0QIU – Research Report), with a price ...